A novel nonsense variant in Nav1.5 cofactor MOG1 eliminates its sodium current increasing effect and may increase the risk of arrhythmiasIdentification of factors driving differences in cost effectiveness of first-line pharmacological therapy for uncomplicated hypertensionIn Memoriam – Lucien Campeau (1927–2010)Potent diuretic effects of prednisone in heart failure patients with refractory diuretic resistancePractical advice for home blood pressure measurementThe 2007 Canadian Hypertension Education Program recommendations for the management of hypertension: part 1- blood pressure measurement, diagnosis and assessment of riskImpact of World Hypertension DayEstimate of the benefits of a population-based reduction in dietary sodium additives on hypertension and its related health care costs in CanadaA study to assess the effects of a broad-spectrum immune modulatory therapy on mortality and morbidity in patients with chronic heart failure: the ACCLAIM trial rationale and designSurgical approach to cardiac papillary fibroelastomasCanadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trialsLack of awareness of heart disease and stroke among Chinese Canadians: results of a pilot study of the Chinese Canadian Cardiovascular Health ProjectThe 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1--blood pressure measurement, diagnosis and assessment of riskReporting on sex-based analysis in clinical trials of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker efficacyThe 2008 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 1 - blood pressure measurement, diagnosis and assessment of riskWorld Hypertension Day and global awarenessThrombolysis versus primary percutaneous coronary intervention for ST elevation myocardial infarctions at Chilliwack General HospitalPublic education on hypertension: a new initiative to improve the prevention, treatment and control of hypertension in CanadaThe 2006 Canadian Hypertension Education Program recommendations for the management of hypertension: Part I--Blood pressure measurement, diagnosis and assessment of riskSex Differences in the Biology and Pathology of the Aging HeartVascular Fibrosis in Aging and Hypertension: Molecular Mechanisms and Clinical ImplicationsDoes Milk Consumption Contribute to Cardiometabolic Health and Overall Diet Quality?Vascular Complications of Cancer ChemotherapyFuture of Sleep-Disordered Breathing Therapy Using a Mechanistic ApproachContemporary use of β-blockers: clinical relevance of subclassificationβ-adrenergic receptor blockers in hypertensionAtenolol vs nonatenolol β-blockers for the treatment of hypertension: a meta-analysisRight ventricular adaptation and failure in pulmonary arterial hypertension.Sex differences in cardiac rehabilitation enrollment: a meta-analysis.β-Blockers in hypertension: studies and meta-analyses over the years.Should All Congestive Heart Failure Patients Have a Routine Sleep Apnea Screening? ConHemodynamics should be the primary approach to diagnosing, following, and managing pulmonary arterial hypertensionResilience in Vulnerable Populations With Type 2 Diabetes Mellitus and Hypertension: A Systematic Review and Meta-analysisPathogenesis of Arrhythmogenic CardiomyopathyThe 2004 Canadian recommendations for the management of hypertension: Part II--TherapySafety of glycoprotein IIb/IIIa inhibitors in urgent or emergency coronary artery bypass graft surgeryProspective validity of measuring angina severity with Canadian Cardiovascular Society class: The ACRE studyA registry of acute myocardial infarction in Kuwait: Patient characteristics and practice patternsAcute myocardial infarction: clinical characteristics, management and outcome in a university medical centre in a developing Middle Eastern countryAntifibrinolytics may be cost saving among recent recipients of combined acetylsalicylic acid and clopidogrel who undergo coronary artery bypass graft surgery
P1433
Q24304891-10AE5DD5-505E-4EDD-8A56-E8459ABBC1D3Q24633649-15331E99-8659-4CED-8378-258FC0F4C0DDQ24633676-4187818E-77F8-4FEF-8893-67F7ADABBAB7Q24644755-DC912C66-71E8-4C03-BCCA-2FF19DD7A2D9Q24645381-2D8246EA-8FA5-42E4-BEE2-ABE24D1DE8E6Q24645401-5F757E80-1A24-4749-BF7D-AC0F53B446F9Q24645484-EE207A9A-2613-4D48-B269-0E9ECBA366C6Q24645546-2C1827DD-9EDB-4E9A-8FEB-2932F21EC7D2Q24647087-27CA27EA-ECF4-46C3-9E2E-0774A4AD3047Q24648158-6DD944AE-9BA1-47CA-BA22-6440D08E07B3Q24650348-7533A757-4156-47B9-B7FE-EE54AFC8E4C2Q24651292-2223BE51-34F7-4ED2-BD09-A1B44B06CB70Q24651499-34E536E3-FB4B-4DD5-82CA-3E8C135D9FB6Q24652838-A67E21DC-F490-4A96-9F7C-66071894F075Q24652860-58BFD5D1-0679-4BD4-928B-6719F09C3F4BQ24652938-262DC31C-0ADB-4618-AAC2-36C3D4D86432Q24657444-09D4E4BC-1698-4906-B088-5E944B42F7D2Q24658005-4070C29D-5C26-4B57-AF10-ABD8ED156E0CQ24658014-FFCE7BC7-5C22-4B0A-B362-A86764512842Q26743420-375D24B5-727A-41A9-A689-5C455EAF6B3DQ26749488-D498DB79-C65E-4AB9-BC9E-C7F3A9EE38C7Q26749505-C8A614BA-702F-4390-8026-64465BF7F889Q26766269-4EB86A4D-3922-47B3-BD01-E41EF0B9B32CQ26827948-03A5AD47-382C-4D09-9B4B-20DE845DE612Q26859049-65A80CAD-F2D7-47B5-8BC8-31A39C8A7BA4Q27000958-9D60B427-F7C5-4A7D-ACAC-BEC4C3495758Q27027913-EB71B1D6-B428-41A6-9BC1-FCD70AA77E56Q27318422-E234E180-35FF-4BA4-AC66-6EA39D7283FAQ27687024-26F0C67F-5991-4BF1-A92C-56EA333187FDQ27691418-0156D0ED-01DB-443A-A870-10FB2B195BD5Q28083056-E1DE12AB-9107-4BD1-98FC-E16DD884A985Q28083099-AFED2263-F40F-431B-BEF3-E9AAEF2ABF86Q28084145-697F0618-3105-4E65-8883-266EFA8EE112Q28085550-5A34596B-34C7-447A-A6B8-BF4E9DA477F5Q28167286-1240AF15-6231-42C2-8DD1-23DFE209F387Q28167672-65D15A29-0296-42B5-B1E7-C30C8A4DDC4CQ28168050-D8873BD4-508E-43DD-903F-AD4CBC809F45Q28169173-A62B20E9-0F89-4911-940E-484EACD573DFQ28169176-F73C6300-5AD1-40B0-96D8-39ED26632AC5Q28169179-20FE2A74-ADAE-49C2-A964-050894C6B8E9
P1433
description
revista científica
@es
rivista scientifica
@it
scientific journal
@en
vědecký časopis
@cs
wetenschappelijk tijdschrift van Elsevier
@nl
wissenschaftliche Zeitschrift
@de
науковий журнал
@uk
مجلة
@ar
वैज्ञानिक पत्रिका
@hi
name
Canadian Journal of Cardiology
@nl
The Canadian Journal of Cardiology
@ast
The Canadian Journal of Cardiology
@da
The Canadian Journal of Cardiology
@en
The Canadian Journal of Cardiology
@es
The Canadian Journal of Cardiology
@fi
The Canadian Journal of Cardiology
@fr
The Canadian Journal of Cardiology
@it
The Canadian Journal of Cardiology
@nb
The Canadian Journal of Cardiology
@nn
type
label
Canadian Journal of Cardiology
@nl
The Canadian Journal of Cardiology
@ast
The Canadian Journal of Cardiology
@da
The Canadian Journal of Cardiology
@en
The Canadian Journal of Cardiology
@es
The Canadian Journal of Cardiology
@fi
The Canadian Journal of Cardiology
@fr
The Canadian Journal of Cardiology
@it
The Canadian Journal of Cardiology
@nb
The Canadian Journal of Cardiology
@nn
altLabel
Canadian Journal of Cardiology
@en
prefLabel
Canadian Journal of Cardiology
@nl
The Canadian Journal of Cardiology
@ast
The Canadian Journal of Cardiology
@da
The Canadian Journal of Cardiology
@en
The Canadian Journal of Cardiology
@es
The Canadian Journal of Cardiology
@fi
The Canadian Journal of Cardiology
@fr
The Canadian Journal of Cardiology
@it
The Canadian Journal of Cardiology
@nb
The Canadian Journal of Cardiology
@nn
P3181
P4616
P1055
P1058
P1156
P123
P1277
P1476
The Canadian Journal of Cardiology
@en
P236
P407
P571
1985-01-01T00:00:00Z
P5963
canadian-journal-of-cardiology